Promptly

Dynamic pathway planning and design Ex-ante impact assessment concerning alternative service pathways

Health/ICT SME

Promptly is an emerging provider of end-to-end Real-World Evidence solutions. In just over 5 years of existence, we have onboarded 40 000+ patients, generating 2M+ data points, from 130+ deployments in 6 different countries across Europe, Brazil and Asia. Promptly is well-versed in R&D projects, including Pre-Commercial Procurements where we made it to the final stages (CareCardia, HSMonitor, ProEmpower) and conducted tendering. We are also experienced in other H2020 and Horizon Europe funding programs, with a high success rate in securing funding and a strong capacity for deployment, both alone and as part of consortia.

Value my organisation can add in a joint tender

Promptly provides a comprehensive suite of solutions for collecting, integrating and analyzing real-world evidence (RWE). Our robust remote patient monitoring (RPM) platform and our expertise in harmonizing clinical, socio-economic, and claims data enable us to generate actionable insights and drive improvement in healthcare outcomes. Our latest technological developments allow for real-time access to data sources scattered across disparate repositories while maintaining the highest of security and privacy. We are experienced in handling a wide range of data granularities, from individual-level data such as patient-reported outcomes measures (PROMs) and electronic health record (EHR)-extracted data to aggregated performance measures and benchmarking.

Areas of cooperation sought

We are open to discussing and well positioned to assist a consortium in Dynamic Care Pathway Modelling and in Ex-ante Impact Assessment of Alternative Service Pathways.

Organisation details

Organisation type:

Health/ICT SME

Organisation size:

Small (< 50 employees and ≤ € 10 m turnover)

Headquarters country:

Portugal

Website:

https://promptlyhealth.com/

Contact

Contact person:

Ana Costa

Job title:

R&D manager